Breaking News

Hovione enters partnership with Ripple Therapeutics

The move is set to expand the use of Ripple's Epidel platform beyond ophthalmic applications

Leucid Bio enters manufacturing agreement with Great Ormond Street

The company expects to file its Clinical Trial Application (CTA) to initiate clinical trials in H1 2023

Synaffix expands licensing agreement with MacroGenics

The expansion comes just a year after the original February 2022 deal, increasing the total potential consideration by up to $2.2 billion

Advancing respiratory health through innovation

Beatriz Noriega Fernandes, PhD, Senior Principal Scientist at Lonza, describes how a QbD and DoE approach was taken to optimise the production proc...

Teknova and Sartorious announce gene therapy collaboration

The collaboration highlights two essential components necessary for the successful recovery of empty and full AAV capsids during anion-exchange (AE...

PCI expands biologics with Midwest “centre of excellence”

New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics

What does 2023 hold for oral solid dosage forms?

Recipharm’s Uwe Hanenberg, Head of Product Development, Oral Solid Dose, and Maria Lundin-Johnson, Head of Formulation Development, explore the lat...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

Pfizer enters into merger with Seagen

The companies expect to complete the transaction in late 2023 or early 2024, subject to fulfilment of customary closing conditions

Catalent expands platform process for viral vectors

Processes can now benefit through increased consistency and efficiency, potentially reducing the time

Expanding capacity through collaboration

Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems, Stevanato Group, t...

Inspiration from unexpected places

How pharmaceutical companies can learn from advances in nicotine delivery

Pharmatech enters alliance with Integra Continuous Manufacturing

The partnership will provide a complete package of services and a proven roadmap for success to address the technical and experiential gaps

Increasing patient compliance with ion exchange excipient taste masking

With a significant number of individuals reporting that they find it difficult to swallow tablets or capsules, and more people admitting to not tak...

BioNxt signs agreement to acquire novel solid oral drug dosage tech

"This coating system could significantly improve oral tablet and oral capsule drug delivery with more precise drug release and predictable dosing."

Enabling oligonucleotide therapeutics with precision targeting methods

Oligonucleotides are a rapidly growing class of therapeutics. This modality appears to offer highly favourable therapeutic characteristics such as...